Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2007 Jan;30(1):59-64.
doi: 10.2337/dc06-1407.

The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes

Affiliations
Multicenter Study

The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes

Darrell M Wilson et al. Diabetes Care. 2007 Jan.

Abstract

Objective: To evaluate the accuracy and precision of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes.

Research design and methods: In 30 children with type 1 diabetes (mean age 11.2 +/- 4.1 years), the Navigator glucose values were compared with reference serum glucose values of blood samples obtained in an inpatient clinical research center and measured in a central laboratory using a hexokinase enzymatic method and in an outpatient setting with a FreeStyle meter. Median absolute difference (AD) and median relative absolute difference (RAD) were computed for sensor-reference and sensor-sensor pairs.

Results: The median AD and RAD were 17 mg/dl and 12%, respectively, for 1,811 inpatient sensor-reference pairs and 20 mg/dl and 14%, respectively, for 8,639 outpatient pairs. The median RAD between two simultaneous Navigator measurements (n = 1,971) was 13%. Ninety-one percent of sensors in the inpatient setting and 81% of sensors in the outpatient setting had a median RAD < or = 20%.

Conclusions: The Navigator's accuracy does not yet approach the accuracy of current-generation home glucose meters, but it is sufficient to believe that the device has the potential to be an important adjunct to treatment of youth with type 1 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Navigator vs. Laboratory Measured Drops in Glucose (A) and Rates of Change (B) during Exercise

References

    1. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive Insulin Therapy in the Medical ICU. N Engl J Med. 2006;354:449–461. - PubMed
    1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med. 2001;345:1359–1367. - PubMed
    1. Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the GlucoWatch® G2™ Biographer in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther. 2003;5:791–800. - PMC - PubMed
    1. Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the CGMS™ in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther. 2003;5:781–789. - PMC - PubMed
    1. Passey RB, Gillum RL, Fuller JB, Urry FM, Giles ML. Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974) Clin Chem. 1977;23:131–139. - PubMed

Publication types